Cargando…
How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit
The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulato...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925443/ https://www.ncbi.nlm.nih.gov/pubmed/33476193 http://dx.doi.org/10.1177/1932296820978399 |
_version_ | 1783659268473356288 |
---|---|
author | Zhang, Jennifer Y. Shang, Trisha Ahn, David Chen, Kong Coté, Gerard Espinoza, Juan Mendez, Carlos E. Spanakis, Elias K. Thompson, Bithika Wallia, Amisha Wisk, Lauren E. Kerr, David Klonoff, David C. |
author_facet | Zhang, Jennifer Y. Shang, Trisha Ahn, David Chen, Kong Coté, Gerard Espinoza, Juan Mendez, Carlos E. Spanakis, Elias K. Thompson, Bithika Wallia, Amisha Wisk, Lauren E. Kerr, David Klonoff, David C. |
author_sort | Zhang, Jennifer Y. |
collection | PubMed |
description | The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulatory, pharmaceutical, and medical device and technology communities. To discuss how to best protect people with diabetes from serious outcomes from COVID-19, Diabetes Technology Society, in collaboration with Sansum Diabetes Research Institute, hosted the “International COVID-19 and Diabetes Virtual Summit” on August 26-27, 2020. This unique, unprecedented real-time conference brought together physicians, scientists, government officials, regulatory experts, industry representatives, and people with diabetes from six continents to review and analyze relationships between COVID-19 and diabetes. Over 800 attendees logged in. The summit consisted of five sessions: (I) Keynotes, (II) Preparedness, (III) Response, (IV) Recovery, and (V) Surveillance; eight parts: (A) Background, (B) Resilience, (C) Outpatient Care, (D) Inpatient Care, (E) Resources, (F) High-Risk Groups, (G) Regulation, and (H) The Future; and 24 sections: (1) Historic Pandemics and Impact on Society, (2) Pathophysiology/Risk Factors for COVID-19, (3) Social Determinants of COVID-19, (4) Preparing for the Future, (5) Medications and Vaccines, (6) Psychology of Patients and Caregivers, (7) Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention, (8) Technology and Telehealth for Diabetes Outpatients, (9) Technology for Inpatients, (10) Management of Diabetes Inpatients with COVID-19, (11) Ethics, (12) Accuracy of Diagnostic Tests, (13) Children, (14) Pregnancy, (15) Economics of Care for COVID-19, (16) Role of Industry, (17) Protection of Healthcare Workers, (18) People with Diabetes, (19) International Responses to COVID-19, (20) Government Policy, (21) Regulation of Tests and Treatments, (22) Digital Health Technology, (23) Big Data Statistics, and 24) Patient Surveillance and Privacy. The two keynote speeches were entitled (1) COVID-19 and Diabetes—Meeting the Challenge and (2) Knowledge Gaps and Research Opportunities for Diabetes and COVID-19. While there was an emphasis on diabetes and its interactions with COVID-19, the panelists also discussed the COVID-19 pandemic in general. The meeting generated many novel ideas for collaboration between experts in medicine, science, government, and industry to develop new technologies and disease treatment paradigms to fight this global pandemic. |
format | Online Article Text |
id | pubmed-7925443 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-79254432021-03-18 How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit Zhang, Jennifer Y. Shang, Trisha Ahn, David Chen, Kong Coté, Gerard Espinoza, Juan Mendez, Carlos E. Spanakis, Elias K. Thompson, Bithika Wallia, Amisha Wisk, Lauren E. Kerr, David Klonoff, David C. J Diabetes Sci Technol Proceedings of Meetings/Conferences The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus has rapidly involved the entire world and exposed the pressing need for collaboration between public health and other stakeholders from the clinical, scientific, regulatory, pharmaceutical, and medical device and technology communities. To discuss how to best protect people with diabetes from serious outcomes from COVID-19, Diabetes Technology Society, in collaboration with Sansum Diabetes Research Institute, hosted the “International COVID-19 and Diabetes Virtual Summit” on August 26-27, 2020. This unique, unprecedented real-time conference brought together physicians, scientists, government officials, regulatory experts, industry representatives, and people with diabetes from six continents to review and analyze relationships between COVID-19 and diabetes. Over 800 attendees logged in. The summit consisted of five sessions: (I) Keynotes, (II) Preparedness, (III) Response, (IV) Recovery, and (V) Surveillance; eight parts: (A) Background, (B) Resilience, (C) Outpatient Care, (D) Inpatient Care, (E) Resources, (F) High-Risk Groups, (G) Regulation, and (H) The Future; and 24 sections: (1) Historic Pandemics and Impact on Society, (2) Pathophysiology/Risk Factors for COVID-19, (3) Social Determinants of COVID-19, (4) Preparing for the Future, (5) Medications and Vaccines, (6) Psychology of Patients and Caregivers, (7) Outpatient Treatment of Diabetes Mellitus and Non-Pharmacologic Intervention, (8) Technology and Telehealth for Diabetes Outpatients, (9) Technology for Inpatients, (10) Management of Diabetes Inpatients with COVID-19, (11) Ethics, (12) Accuracy of Diagnostic Tests, (13) Children, (14) Pregnancy, (15) Economics of Care for COVID-19, (16) Role of Industry, (17) Protection of Healthcare Workers, (18) People with Diabetes, (19) International Responses to COVID-19, (20) Government Policy, (21) Regulation of Tests and Treatments, (22) Digital Health Technology, (23) Big Data Statistics, and 24) Patient Surveillance and Privacy. The two keynote speeches were entitled (1) COVID-19 and Diabetes—Meeting the Challenge and (2) Knowledge Gaps and Research Opportunities for Diabetes and COVID-19. While there was an emphasis on diabetes and its interactions with COVID-19, the panelists also discussed the COVID-19 pandemic in general. The meeting generated many novel ideas for collaboration between experts in medicine, science, government, and industry to develop new technologies and disease treatment paradigms to fight this global pandemic. SAGE Publications 2021-01-21 /pmc/articles/PMC7925443/ /pubmed/33476193 http://dx.doi.org/10.1177/1932296820978399 Text en © 2021 Diabetes Technology Society https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Proceedings of Meetings/Conferences Zhang, Jennifer Y. Shang, Trisha Ahn, David Chen, Kong Coté, Gerard Espinoza, Juan Mendez, Carlos E. Spanakis, Elias K. Thompson, Bithika Wallia, Amisha Wisk, Lauren E. Kerr, David Klonoff, David C. How to Best Protect People With Diabetes From the Impact of SARS-CoV-2: Report of the International COVID-19 and Diabetes Summit |
title | How to Best Protect People With Diabetes From the Impact of
SARS-CoV-2: Report of the International COVID-19 and Diabetes
Summit |
title_full | How to Best Protect People With Diabetes From the Impact of
SARS-CoV-2: Report of the International COVID-19 and Diabetes
Summit |
title_fullStr | How to Best Protect People With Diabetes From the Impact of
SARS-CoV-2: Report of the International COVID-19 and Diabetes
Summit |
title_full_unstemmed | How to Best Protect People With Diabetes From the Impact of
SARS-CoV-2: Report of the International COVID-19 and Diabetes
Summit |
title_short | How to Best Protect People With Diabetes From the Impact of
SARS-CoV-2: Report of the International COVID-19 and Diabetes
Summit |
title_sort | how to best protect people with diabetes from the impact of
sars-cov-2: report of the international covid-19 and diabetes
summit |
topic | Proceedings of Meetings/Conferences |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925443/ https://www.ncbi.nlm.nih.gov/pubmed/33476193 http://dx.doi.org/10.1177/1932296820978399 |
work_keys_str_mv | AT zhangjennifery howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT shangtrisha howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT ahndavid howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT chenkong howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT cotegerard howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT espinozajuan howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT mendezcarlose howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT spanakiseliask howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT thompsonbithika howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT walliaamisha howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT wisklaurene howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT kerrdavid howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit AT klonoffdavidc howtobestprotectpeoplewithdiabetesfromtheimpactofsarscov2reportoftheinternationalcovid19anddiabetessummit |